Atrial Fibrillation/Flutter Pathway Improves Care

Atrial fibrillation/flutter (AFF) increases risk for stroke and is an indication for anticoagulation in appropriate patients (as determined by the CHADS-VASC and HAS-BLED decision scores). These authors in British Columbia developed an evidence-based emergency department (ED) clinical care pathway for AFF to improve compliance with accepted guidelines and improve care.

The pathway was integrated into the electronic ordering system, and included decision tools, suggested medications and doses, and consultation and referral guidance. Bridging anticoagulation was not recommended for patients discharged with warfarin. Approximately 130 patients with uncomplicated AFF were enrolled in the 3 months prior to pathway implementation, and roughly 170 …